CN117143907A - Broom corn millet genetic transformation method - Google Patents
Broom corn millet genetic transformation method Download PDFInfo
- Publication number
- CN117143907A CN117143907A CN202210565362.XA CN202210565362A CN117143907A CN 117143907 A CN117143907 A CN 117143907A CN 202210565362 A CN202210565362 A CN 202210565362A CN 117143907 A CN117143907 A CN 117143907A
- Authority
- CN
- China
- Prior art keywords
- medium
- callus
- culture medium
- culture
- broom corn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000007199 Panicum miliaceum Nutrition 0.000 title claims abstract description 41
- 230000002068 genetic effect Effects 0.000 title claims abstract description 28
- 238000011426 transformation method Methods 0.000 title abstract description 19
- 244000022203 blackseeded proso millet Species 0.000 title description 43
- 206010020649 Hyperkeratosis Diseases 0.000 claims abstract description 86
- 238000000034 method Methods 0.000 claims abstract description 61
- 230000009466 transformation Effects 0.000 claims abstract description 36
- 239000001963 growth medium Substances 0.000 claims abstract description 26
- 241000589158 Agrobacterium Species 0.000 claims abstract description 14
- 244000022185 broomcorn panic Species 0.000 claims abstract 7
- 239000002609 medium Substances 0.000 claims description 87
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 42
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 claims description 38
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 38
- 108090000623 proteins and genes Proteins 0.000 claims description 36
- 230000001954 sterilising effect Effects 0.000 claims description 31
- 229930006000 Sucrose Natural products 0.000 claims description 30
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 30
- 239000005720 sucrose Substances 0.000 claims description 30
- 238000004659 sterilization and disinfection Methods 0.000 claims description 29
- 239000012881 co-culture medium Substances 0.000 claims description 28
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 28
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 28
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 28
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 28
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 28
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 28
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 28
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 28
- 229960003512 nicotinic acid Drugs 0.000 claims description 27
- 235000001968 nicotinic acid Nutrition 0.000 claims description 27
- 239000011664 nicotinic acid Substances 0.000 claims description 27
- 230000004069 differentiation Effects 0.000 claims description 21
- 108010079058 casein hydrolysate Proteins 0.000 claims description 20
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 20
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 20
- 239000011665 D-biotin Substances 0.000 claims description 19
- 235000000638 D-biotin Nutrition 0.000 claims description 19
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 19
- 229960000367 inositol Drugs 0.000 claims description 19
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 19
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 19
- 229920002148 Gellan gum Polymers 0.000 claims description 17
- 230000006698 induction Effects 0.000 claims description 16
- 239000000047 product Substances 0.000 claims description 16
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 claims description 15
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 claims description 15
- 229960001669 kinetin Drugs 0.000 claims description 15
- 238000012216 screening Methods 0.000 claims description 13
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 12
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 239000013598 vector Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 7
- 238000005286 illumination Methods 0.000 claims description 7
- 229940027257 timentin Drugs 0.000 claims description 7
- 229920001817 Agar Polymers 0.000 claims description 5
- 101710134784 Agnoprotein Proteins 0.000 claims description 5
- 239000008272 agar Substances 0.000 claims description 5
- 150000001413 amino acids Chemical group 0.000 claims description 5
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 229940068840 d-biotin Drugs 0.000 claims description 4
- 229960000310 isoleucine Drugs 0.000 claims description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000003501 co-culture Methods 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 230000000408 embryogenic effect Effects 0.000 claims description 3
- 238000005194 fractionation Methods 0.000 claims description 3
- 229930027917 kanamycin Natural products 0.000 claims description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 3
- 229960000318 kanamycin Drugs 0.000 claims description 3
- 229930182823 kanamycin A Natural products 0.000 claims description 3
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 claims description 3
- 229960001225 rifampicin Drugs 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 abstract description 13
- 230000008569 process Effects 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 12
- 230000009261 transgenic effect Effects 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 230000001404 mediated effect Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 244000062793 Sorghum vulgare Species 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 235000019713 millet Nutrition 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000005090 green fluorescent protein Substances 0.000 description 4
- 239000006870 ms-medium Substances 0.000 description 4
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000005022 packaging material Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 2
- HGLKOTPFWOMPOB-MEYUZBJRSA-N Leu-Thr-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HGLKOTPFWOMPOB-MEYUZBJRSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- RBRNEFJTEHPDSL-ACRUOGEOSA-N Phe-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 RBRNEFJTEHPDSL-ACRUOGEOSA-N 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 108010051242 phenylalanylserine Proteins 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011833 salt mixture Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- AXFMEGAFCUULFV-BLFANLJRSA-N (2s)-2-[[(2s)-1-[(2s,3r)-2-amino-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]pentanedioic acid Chemical compound CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AXFMEGAFCUULFV-BLFANLJRSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- LZRNYBIJOSKKRJ-XVYDVKMFSA-N Ala-Asp-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LZRNYBIJOSKKRJ-XVYDVKMFSA-N 0.000 description 1
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 1
- IFTVANMRTIHKML-WDSKDSINSA-N Ala-Gln-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O IFTVANMRTIHKML-WDSKDSINSA-N 0.000 description 1
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 1
- NBTGEURICRTMGL-WHFBIAKZSA-N Ala-Gly-Ser Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 1
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 1
- LNNSWWRRYJLGNI-NAKRPEOUSA-N Ala-Ile-Val Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O LNNSWWRRYJLGNI-NAKRPEOUSA-N 0.000 description 1
- OYJCVIGKMXUVKB-GARJFASQSA-N Ala-Leu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N OYJCVIGKMXUVKB-GARJFASQSA-N 0.000 description 1
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 1
- YCRAFFCYWOUEOF-DLOVCJGASA-N Ala-Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 YCRAFFCYWOUEOF-DLOVCJGASA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- 101100519158 Arabidopsis thaliana PCR2 gene Proteins 0.000 description 1
- GXCSUJQOECMKPV-CIUDSAMLSA-N Arg-Ala-Gln Chemical compound C[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O GXCSUJQOECMKPV-CIUDSAMLSA-N 0.000 description 1
- KGSJCPBERYUXCN-BPNCWPANSA-N Arg-Ala-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KGSJCPBERYUXCN-BPNCWPANSA-N 0.000 description 1
- TTXYKSADPSNOIF-IHRRRGAJSA-N Arg-Asp-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O TTXYKSADPSNOIF-IHRRRGAJSA-N 0.000 description 1
- JTWOBPNAVBESFW-FXQIFTODSA-N Arg-Cys-Asp Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)CN=C(N)N JTWOBPNAVBESFW-FXQIFTODSA-N 0.000 description 1
- IRRMIGDCPOPZJW-ULQDDVLXSA-N Arg-His-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IRRMIGDCPOPZJW-ULQDDVLXSA-N 0.000 description 1
- ATABBWFGOHKROJ-GUBZILKMSA-N Arg-Pro-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O ATABBWFGOHKROJ-GUBZILKMSA-N 0.000 description 1
- DNLQVHBBMPZUGJ-BQBZGAKWSA-N Arg-Ser-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O DNLQVHBBMPZUGJ-BQBZGAKWSA-N 0.000 description 1
- YNSUUAOAFCVINY-OSUNSFLBSA-N Arg-Thr-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YNSUUAOAFCVINY-OSUNSFLBSA-N 0.000 description 1
- LFWOQHSQNCKXRU-UFYCRDLUSA-N Arg-Tyr-Phe Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 LFWOQHSQNCKXRU-UFYCRDLUSA-N 0.000 description 1
- QCTOLCVIGRLMQS-HRCADAONSA-N Arg-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O QCTOLCVIGRLMQS-HRCADAONSA-N 0.000 description 1
- MEFGKQUUYZOLHM-GMOBBJLQSA-N Asn-Arg-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MEFGKQUUYZOLHM-GMOBBJLQSA-N 0.000 description 1
- QHBMKQWOIYJYMI-BYULHYEWSA-N Asn-Asn-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O QHBMKQWOIYJYMI-BYULHYEWSA-N 0.000 description 1
- WQLJRNRLHWJIRW-KKUMJFAQSA-N Asn-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N)O WQLJRNRLHWJIRW-KKUMJFAQSA-N 0.000 description 1
- XLZCLJRGGMBKLR-PCBIJLKTSA-N Asn-Ile-Phe Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XLZCLJRGGMBKLR-PCBIJLKTSA-N 0.000 description 1
- LSJQOMAZIKQMTJ-SRVKXCTJSA-N Asn-Phe-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LSJQOMAZIKQMTJ-SRVKXCTJSA-N 0.000 description 1
- WUQXMTITJLFXAU-JIOCBJNQSA-N Asn-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N)O WUQXMTITJLFXAU-JIOCBJNQSA-N 0.000 description 1
- RTFXPCYMDYBZNQ-SRVKXCTJSA-N Asn-Tyr-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O RTFXPCYMDYBZNQ-SRVKXCTJSA-N 0.000 description 1
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 1
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 1
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 1
- BFOYULZBKYOKAN-OLHMAJIHSA-N Asp-Asp-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BFOYULZBKYOKAN-OLHMAJIHSA-N 0.000 description 1
- KVPHTGVUMJGMCX-BIIVOSGPSA-N Asp-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)N)C(=O)O KVPHTGVUMJGMCX-BIIVOSGPSA-N 0.000 description 1
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 1
- LNENWJXDHCFVOF-DCAQKATOSA-N Asp-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)O)N LNENWJXDHCFVOF-DCAQKATOSA-N 0.000 description 1
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VFGADOJXRLWTBU-JBDRJPRFSA-N Cys-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N VFGADOJXRLWTBU-JBDRJPRFSA-N 0.000 description 1
- POSRGGKLRWCUBE-CIUDSAMLSA-N Cys-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N POSRGGKLRWCUBE-CIUDSAMLSA-N 0.000 description 1
- CHRCKSPMGYDLIA-SRVKXCTJSA-N Cys-Phe-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O CHRCKSPMGYDLIA-SRVKXCTJSA-N 0.000 description 1
- NAPULYCVEVVFRB-HEIBUPTGSA-N Cys-Thr-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CS NAPULYCVEVVFRB-HEIBUPTGSA-N 0.000 description 1
- VIOQRFNAZDMVLO-NRPADANISA-N Cys-Val-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O VIOQRFNAZDMVLO-NRPADANISA-N 0.000 description 1
- 108010090461 DFG peptide Proteins 0.000 description 1
- 206010017472 Fumbling Diseases 0.000 description 1
- 101150066002 GFP gene Proteins 0.000 description 1
- NPTGGVQJYRSMCM-GLLZPBPUSA-N Gln-Gln-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NPTGGVQJYRSMCM-GLLZPBPUSA-N 0.000 description 1
- LTXLIIZACMCQTO-GUBZILKMSA-N Gln-His-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N LTXLIIZACMCQTO-GUBZILKMSA-N 0.000 description 1
- HSHCEAUPUPJPTE-JYJNAYRXSA-N Gln-Leu-Tyr Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N HSHCEAUPUPJPTE-JYJNAYRXSA-N 0.000 description 1
- KUBFPYIMAGXGBT-ACZMJKKPSA-N Gln-Ser-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KUBFPYIMAGXGBT-ACZMJKKPSA-N 0.000 description 1
- LPIKVBWNNVFHCQ-GUBZILKMSA-N Gln-Ser-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LPIKVBWNNVFHCQ-GUBZILKMSA-N 0.000 description 1
- ARYKRXHBIPLULY-XKBZYTNZSA-N Gln-Thr-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ARYKRXHBIPLULY-XKBZYTNZSA-N 0.000 description 1
- WOMUDRVDJMHTCV-DCAQKATOSA-N Glu-Arg-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WOMUDRVDJMHTCV-DCAQKATOSA-N 0.000 description 1
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 1
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 1
- OGNJZUXUTPQVBR-BQBZGAKWSA-N Glu-Gly-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OGNJZUXUTPQVBR-BQBZGAKWSA-N 0.000 description 1
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 1
- MFNUFCFRAZPJFW-JYJNAYRXSA-N Glu-Lys-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFNUFCFRAZPJFW-JYJNAYRXSA-N 0.000 description 1
- WIKMTDVSCUJIPJ-CIUDSAMLSA-N Glu-Ser-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N WIKMTDVSCUJIPJ-CIUDSAMLSA-N 0.000 description 1
- KIEICAOUSNYOLM-NRPADANISA-N Glu-Val-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O KIEICAOUSNYOLM-NRPADANISA-N 0.000 description 1
- MLILEEIVMRUYBX-NHCYSSNCSA-N Glu-Val-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O MLILEEIVMRUYBX-NHCYSSNCSA-N 0.000 description 1
- OCQUNKSFDYDXBG-QXEWZRGKSA-N Gly-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OCQUNKSFDYDXBG-QXEWZRGKSA-N 0.000 description 1
- DWUKOTKSTDWGAE-BQBZGAKWSA-N Gly-Asn-Arg Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DWUKOTKSTDWGAE-BQBZGAKWSA-N 0.000 description 1
- BGVYNAQWHSTTSP-BYULHYEWSA-N Gly-Asn-Ile Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BGVYNAQWHSTTSP-BYULHYEWSA-N 0.000 description 1
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 1
- LHRXAHLCRMQBGJ-RYUDHWBXSA-N Gly-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CN LHRXAHLCRMQBGJ-RYUDHWBXSA-N 0.000 description 1
- HQRHFUYMGCHHJS-LURJTMIESA-N Gly-Gly-Arg Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N HQRHFUYMGCHHJS-LURJTMIESA-N 0.000 description 1
- ITZOBNKQDZEOCE-NHCYSSNCSA-N Gly-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CN ITZOBNKQDZEOCE-NHCYSSNCSA-N 0.000 description 1
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 1
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 1
- DUAWRXXTOQOECJ-JSGCOSHPSA-N Gly-Tyr-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O DUAWRXXTOQOECJ-JSGCOSHPSA-N 0.000 description 1
- NGRPGJGKJMUGDM-XVKPBYJWSA-N Gly-Val-Gln Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NGRPGJGKJMUGDM-XVKPBYJWSA-N 0.000 description 1
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 1
- KZTLOHBDLMIFSH-XVYDVKMFSA-N His-Ala-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O KZTLOHBDLMIFSH-XVYDVKMFSA-N 0.000 description 1
- UZZXGLOJRZKYEL-DJFWLOJKSA-N His-Asn-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UZZXGLOJRZKYEL-DJFWLOJKSA-N 0.000 description 1
- TWROVBNEHJSXDG-IHRRRGAJSA-N His-Leu-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O TWROVBNEHJSXDG-IHRRRGAJSA-N 0.000 description 1
- IGBBXBFSLKRHJB-BZSNNMDCSA-N His-Lys-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 IGBBXBFSLKRHJB-BZSNNMDCSA-N 0.000 description 1
- WYSJPCTWSBJFCO-AVGNSLFASA-N His-Met-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CN=CN1)N WYSJPCTWSBJFCO-AVGNSLFASA-N 0.000 description 1
- PYNPBMCLAKTHJL-SRVKXCTJSA-N His-Pro-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O PYNPBMCLAKTHJL-SRVKXCTJSA-N 0.000 description 1
- UXZMINKIEWBEQU-SZMVWBNQSA-N His-Trp-Gln Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N UXZMINKIEWBEQU-SZMVWBNQSA-N 0.000 description 1
- VSZALHITQINTGC-GHCJXIJMSA-N Ile-Ala-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VSZALHITQINTGC-GHCJXIJMSA-N 0.000 description 1
- HGNUKGZQASSBKQ-PCBIJLKTSA-N Ile-Asp-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HGNUKGZQASSBKQ-PCBIJLKTSA-N 0.000 description 1
- REJKOQYVFDEZHA-SLBDDTMCSA-N Ile-Asp-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N REJKOQYVFDEZHA-SLBDDTMCSA-N 0.000 description 1
- LOXMWQOKYBGCHF-JBDRJPRFSA-N Ile-Cys-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O LOXMWQOKYBGCHF-JBDRJPRFSA-N 0.000 description 1
- KFVUBLZRFSVDGO-BYULHYEWSA-N Ile-Gly-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O KFVUBLZRFSVDGO-BYULHYEWSA-N 0.000 description 1
- IGJWJGIHUFQANP-LAEOZQHASA-N Ile-Gly-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N IGJWJGIHUFQANP-LAEOZQHASA-N 0.000 description 1
- NYEYYMLUABXDMC-NHCYSSNCSA-N Ile-Gly-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)N NYEYYMLUABXDMC-NHCYSSNCSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 1
- ZYLJULGXQDNXDK-GUBZILKMSA-N Leu-Gln-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ZYLJULGXQDNXDK-GUBZILKMSA-N 0.000 description 1
- VBZOAGIPCULURB-QWRGUYRKSA-N Leu-Gly-His Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N VBZOAGIPCULURB-QWRGUYRKSA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
- QNTJIDXQHWUBKC-BZSNNMDCSA-N Leu-Lys-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QNTJIDXQHWUBKC-BZSNNMDCSA-N 0.000 description 1
- DDVHDMSBLRAKNV-IHRRRGAJSA-N Leu-Met-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O DDVHDMSBLRAKNV-IHRRRGAJSA-N 0.000 description 1
- BMVFXOQHDQZAQU-DCAQKATOSA-N Leu-Pro-Asp Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N BMVFXOQHDQZAQU-DCAQKATOSA-N 0.000 description 1
- VULJUQZPSOASBZ-SRVKXCTJSA-N Leu-Pro-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O VULJUQZPSOASBZ-SRVKXCTJSA-N 0.000 description 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 1
- PPGBXYKMUMHFBF-KATARQTJSA-N Leu-Ser-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PPGBXYKMUMHFBF-KATARQTJSA-N 0.000 description 1
- ICYRCNICGBJLGM-HJGDQZAQSA-N Leu-Thr-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O ICYRCNICGBJLGM-HJGDQZAQSA-N 0.000 description 1
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 1
- GQUDMNDPQTXZRV-DCAQKATOSA-N Lys-Arg-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GQUDMNDPQTXZRV-DCAQKATOSA-N 0.000 description 1
- QQUJSUFWEDZQQY-AVGNSLFASA-N Lys-Gln-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN QQUJSUFWEDZQQY-AVGNSLFASA-N 0.000 description 1
- MXMDJEJWERYPMO-XUXIUFHCSA-N Lys-Ile-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MXMDJEJWERYPMO-XUXIUFHCSA-N 0.000 description 1
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 1
- OIQSIMFSVLLWBX-VOAKCMCISA-N Lys-Leu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OIQSIMFSVLLWBX-VOAKCMCISA-N 0.000 description 1
- LNMKRJJLEFASGA-BZSNNMDCSA-N Lys-Phe-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O LNMKRJJLEFASGA-BZSNNMDCSA-N 0.000 description 1
- VHGIWFGJIHTASW-FXQIFTODSA-N Met-Ala-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O VHGIWFGJIHTASW-FXQIFTODSA-N 0.000 description 1
- GODBLDDYHFTUAH-CIUDSAMLSA-N Met-Asp-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O GODBLDDYHFTUAH-CIUDSAMLSA-N 0.000 description 1
- VOOINLQYUZOREH-SRVKXCTJSA-N Met-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCSC)N VOOINLQYUZOREH-SRVKXCTJSA-N 0.000 description 1
- PZUUMQPMHBJJKE-AVGNSLFASA-N Met-Leu-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCNC(N)=N PZUUMQPMHBJJKE-AVGNSLFASA-N 0.000 description 1
- HAQLBBVZAGMESV-IHRRRGAJSA-N Met-Lys-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O HAQLBBVZAGMESV-IHRRRGAJSA-N 0.000 description 1
- KRLKICLNEICJGV-STQMWFEESA-N Met-Phe-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 KRLKICLNEICJGV-STQMWFEESA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- FRPVPGRXUKFEQE-YDHLFZDLSA-N Phe-Asp-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FRPVPGRXUKFEQE-YDHLFZDLSA-N 0.000 description 1
- BIYWZVCPZIFGPY-QWRGUYRKSA-N Phe-Gly-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O BIYWZVCPZIFGPY-QWRGUYRKSA-N 0.000 description 1
- KCIKTPHTEYBXMG-BVSLBCMMSA-N Phe-Trp-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O KCIKTPHTEYBXMG-BVSLBCMMSA-N 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 1
- NHDVNAKDACFHPX-GUBZILKMSA-N Pro-Arg-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O NHDVNAKDACFHPX-GUBZILKMSA-N 0.000 description 1
- VCYJKOLZYPYGJV-AVGNSLFASA-N Pro-Arg-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VCYJKOLZYPYGJV-AVGNSLFASA-N 0.000 description 1
- OBVCYFIHIIYIQF-CIUDSAMLSA-N Pro-Asn-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OBVCYFIHIIYIQF-CIUDSAMLSA-N 0.000 description 1
- ZPPVJIJMIKTERM-YUMQZZPRSA-N Pro-Gln-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]1CCCN1 ZPPVJIJMIKTERM-YUMQZZPRSA-N 0.000 description 1
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 1
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 1
- LPGSNRSLPHRNBW-AVGNSLFASA-N Pro-His-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 LPGSNRSLPHRNBW-AVGNSLFASA-N 0.000 description 1
- AJBQTGZIZQXBLT-STQMWFEESA-N Pro-Phe-Gly Chemical compound C([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 AJBQTGZIZQXBLT-STQMWFEESA-N 0.000 description 1
- YIPFBJGBRCJJJD-FHWLQOOXSA-N Pro-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@@H]3CCCN3 YIPFBJGBRCJJJD-FHWLQOOXSA-N 0.000 description 1
- KHRLUIPIMIQFGT-AVGNSLFASA-N Pro-Val-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHRLUIPIMIQFGT-AVGNSLFASA-N 0.000 description 1
- ZMLRZBWCXPQADC-TUAOUCFPSA-N Pro-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ZMLRZBWCXPQADC-TUAOUCFPSA-N 0.000 description 1
- 101150090155 R gene Proteins 0.000 description 1
- IYCBDVBJWDXQRR-FXQIFTODSA-N Ser-Ala-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IYCBDVBJWDXQRR-FXQIFTODSA-N 0.000 description 1
- BGOWRLSWJCVYAQ-CIUDSAMLSA-N Ser-Asp-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BGOWRLSWJCVYAQ-CIUDSAMLSA-N 0.000 description 1
- VDVYTKZBMFADQH-AVGNSLFASA-N Ser-Gln-Tyr Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 VDVYTKZBMFADQH-AVGNSLFASA-N 0.000 description 1
- SMIDBHKWSYUBRZ-ACZMJKKPSA-N Ser-Glu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O SMIDBHKWSYUBRZ-ACZMJKKPSA-N 0.000 description 1
- YRBGKVIWMNEVCZ-WDSKDSINSA-N Ser-Glu-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O YRBGKVIWMNEVCZ-WDSKDSINSA-N 0.000 description 1
- VQBCMLMPEWPUTB-ACZMJKKPSA-N Ser-Glu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VQBCMLMPEWPUTB-ACZMJKKPSA-N 0.000 description 1
- RJHJPZQOMKCSTP-CIUDSAMLSA-N Ser-His-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O RJHJPZQOMKCSTP-CIUDSAMLSA-N 0.000 description 1
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 1
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 description 1
- BEBVVQPDSHHWQL-NRPADANISA-N Ser-Val-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O BEBVVQPDSHHWQL-NRPADANISA-N 0.000 description 1
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 1
- CAJFZCICSVBOJK-SHGPDSBTSA-N Thr-Ala-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAJFZCICSVBOJK-SHGPDSBTSA-N 0.000 description 1
- XSLXHSYIVPGEER-KZVJFYERSA-N Thr-Ala-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XSLXHSYIVPGEER-KZVJFYERSA-N 0.000 description 1
- CAGTXGDOIFXLPC-KZVJFYERSA-N Thr-Arg-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CCCN=C(N)N CAGTXGDOIFXLPC-KZVJFYERSA-N 0.000 description 1
- LHEZGZQRLDBSRR-WDCWCFNPSA-N Thr-Glu-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LHEZGZQRLDBSRR-WDCWCFNPSA-N 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 1
- NBIIPOKZPUGATB-BWBBJGPYSA-N Thr-Ser-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O NBIIPOKZPUGATB-BWBBJGPYSA-N 0.000 description 1
- CSZFFQBUTMGHAH-UAXMHLISSA-N Thr-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O CSZFFQBUTMGHAH-UAXMHLISSA-N 0.000 description 1
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 1
- SBYQHZCMVSPQCS-RCWTZXSCSA-N Thr-Val-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O SBYQHZCMVSPQCS-RCWTZXSCSA-N 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- MQVGIFJSFFVGFW-XEGUGMAKSA-N Trp-Ala-Glu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MQVGIFJSFFVGFW-XEGUGMAKSA-N 0.000 description 1
- IKUMWSDCGQVGHC-UMPQAUOISA-N Trp-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CNC3=CC=CC=C32)N)O IKUMWSDCGQVGHC-UMPQAUOISA-N 0.000 description 1
- QUILOGWWLXMSAT-IHRRRGAJSA-N Tyr-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QUILOGWWLXMSAT-IHRRRGAJSA-N 0.000 description 1
- KLOZTPOXVVRVAQ-DZKIICNBSA-N Tyr-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KLOZTPOXVVRVAQ-DZKIICNBSA-N 0.000 description 1
- UDNYEPLJTRDMEJ-RCOVLWMOSA-N Val-Asn-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N UDNYEPLJTRDMEJ-RCOVLWMOSA-N 0.000 description 1
- QGFPYRPIUXBYGR-YDHLFZDLSA-N Val-Asn-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N QGFPYRPIUXBYGR-YDHLFZDLSA-N 0.000 description 1
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 1
- VFOHXOLPLACADK-GVXVVHGQSA-N Val-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N VFOHXOLPLACADK-GVXVVHGQSA-N 0.000 description 1
- ROLGIBMFNMZANA-GVXVVHGQSA-N Val-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N ROLGIBMFNMZANA-GVXVVHGQSA-N 0.000 description 1
- AGXGCFSECFQMKB-NHCYSSNCSA-N Val-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N AGXGCFSECFQMKB-NHCYSSNCSA-N 0.000 description 1
- HPANGHISDXDUQY-ULQDDVLXSA-N Val-Lys-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HPANGHISDXDUQY-ULQDDVLXSA-N 0.000 description 1
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 1
- CEKSLIVSNNGOKH-KZVJFYERSA-N Val-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](C(C)C)N)O CEKSLIVSNNGOKH-KZVJFYERSA-N 0.000 description 1
- GTACFKZDQFTVAI-STECZYCISA-N Val-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 GTACFKZDQFTVAI-STECZYCISA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 101150010487 are gene Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- -1 e.g. Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010062266 glycyl-glycyl-argininal Proteins 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010012988 lysyl-glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 108010012581 phenylalanylglutamate Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 108700004896 tripeptide FEG Proteins 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 108700026215 vpr Genes Proteins 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/002—Culture media for tissue culture
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/008—Methods for regeneration to complete plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Botany (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The application relates to a high-efficiency broom corn millet genetic transformation method. The applicant has repeatedly searched and tested, and optimized the multiple steps of the established broom corn millet genetic transformation method. Firstly, selecting mature seeds of plants as explants, wherein the sources of the mature seeds are not limited by seasons, and the acquisition period is short; secondly, on the basis of selecting seeds as explants, primary callus is selected for infection and genetic transformation of agrobacterium, so that the transformation efficiency is further improved, and the transformation method is optimized; finally, by adjusting the culture medium used in the callus culture process, the optimal culture medium combination is obtained, the transformation efficiency is further improved, and the transformation method is optimized. Thus, the efficient broom corn millet genetic transformation method is obtained.
Description
Technical Field
The application relates to the technical field of biotechnology and plant bioengineering, in particular to a high-efficiency broom corn millet genetic transformation method.
Background
The transformation techniques that have been used at present are gene gun method, agrobacterium-mediated method, pollen tube channel method, PEG-mediated method, ovary injection method, ultrasonic method, electrode method, etc. Among the mainstream transformation methods of cereals are the gene gun method and the agrobacterium-mediated method. The gene gun bombardment method has the defects of relatively complex integration mode, relatively unstable passage of exogenous gene expression and easy technical limitation. The agrobacterium-mediated method has the advantages of capability of transforming larger DNA fragments, simpler operation, low cost, stable inheritance of the obtained transgenic successful plants and the like, although the agrobacterium-mediated method has the defect that a vector skeleton and even chromosome fragments can be transferred; therefore, agrobacterium-mediated transgene is one of the current methods of genetic transformation of cereals.
In agrobacterium-mediated genetic transformation, the establishment of a good receptor system is key to genetic transformation; currently, the receptors commonly used are: immature embryo, seed, stem node meristem, young spike, stem tip, root tip, etc. There are many restrictions on the acquisition of part of the explants, which can limit the routine transformation of the explants.
Broom corn millet (Panicum miliaceum l), also known as millet, belongs to the family of grasses, the heterologous 4-fold (2n=4×9=36), annual cereals. Is one of the traditional five cereals in China and is also one of the crops which are domesticated first by people in China. It is rich in multiple vitamins, amino acids and unsaturated fatty acids, and is beneficial to health after long-term consumption, and has important effect on improving the dietary structure of China; broom corn millet has a shorter growth cycle and better stress resistance, is used as a C4 crop, has higher carbon fixing capacity and higher water and fertilizer utilization capacity than a C3 crop, and is an ideal drought-resistant pioneer crop.
Broom corn millet has successfully completed whole genome sequencing in 2019 (team Lai Jincheng and Song Weibin of Chinese agricultural university), which also opens up functional genomics research of broom corn millet. However, there is no available broom corn millet genetic transformation technology system in the global scope so far, which makes the genetic improvement of broom corn millet by genetic transformation methods, especially genetic editing technology strategies, very limited.
Therefore, a genetic transformation system of broom corn millet is created, and the rapid increase of the yield and the improvement of the quality are developed through a gene editing technology system (CRISPR-Cas 12i and Cas12 j) of independent intellectual property rights, so that the method has great research significance in further improving and enriching the variety of food crops in China.
Disclosure of Invention
In order to solve the problems, the inventor of the application establishes a genetic transformation method of broom corn millet for the first time through a great deal of experiments. Furthermore, the applicant optimizes a plurality of steps of the established broom corn millet genetic transformation method through repeated fumbling, and the efficient broom corn millet genetic transformation method is obtained. Thus, the present application has been completed.
Accordingly, in a first aspect, the present application provides a method for genetic transformation of millet, the method comprising:
step (1): taking broom corn millet seeds as explants to obtain primary callus;
step (2): transforming target genes and hygromycin resistance genes into the primary callus obtained in the step (1) through agrobacterium;
step (3): putting the product obtained in the step (2) into a co-culture medium for co-culture;
step (4): placing the product obtained in the step (3) into an induction culture medium for culture;
step (5): placing the product obtained in the step (4) into a screening culture medium containing 50mg/L hygromycin to screen callus containing hygromycin resistance genes;
step (6): placing the product obtained in the step (5) into a pre-differentiation culture medium to enable the callus to bud;
step (7): placing the product obtained in the step (6) into a differentiation medium to root the callus;
step (8): placing the product obtained in the step (7) into a seedling culture medium so as to enable seedlings of the callus to grow.
In certain embodiments, the amino acid sequence of the gene of interest is shown in SEQ ID NO. 2.
In certain embodiments, the hygromycin resistance gene has an amino acid sequence as set forth in SEQ ID NO. 1.
In certain embodiments, in step (3), the co-culture medium has a ph=5.4, which comprises or consists of MS basal medium supplemented with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 50mg/L inositol, 0.1mg/L thiamine hydrochloride, 30g/L sucrose and 2mg/L2,4-D and 0.5mg/L kinetin; and 200. Mu.M/L acetosyringone was added after sterilization.
In certain embodiments, in step (3), the co-culture medium is a solid co-culture medium. In certain embodiments, the solid co-culture medium further comprises 3g/LPhytagel TM 。
In certain embodiments, the solid co-culture medium has a ph=5.4, which comprises or is supplemented with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 50mg/L inositol, 0.1mg/L thiamine hydrochloride, 30g/L sucrose and 2mg/L2,4-D,0.5mg/L kinetin, 3g/L Phytagel from MS minimal medium TM Composition; and 200. Mu.M/L acetosyringone was added after sterilization.
In certain embodiments, in step (4), the induction medium has a ph=5.8, which comprises or is supplemented with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 50mg/L inositol, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin and 3g/LPhytagel from MS minimal medium TM Composition; and, after sterilization, 2mg/L AgNO is added 3 。
In certain embodiments, in step (5), the screening medium has a ph=5.8, which comprises or is supplemented with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 50mg/L inositol, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin and 3g/LPhytagel from MS minimal medium TM Composition; and, after sterilization, 2mg/L AgNO is added 3 50mg/L hygromycin, and 150mg/L Timentin.
In certain embodiments, at step (iv)(6) Wherein the pre-fractionation medium has a pH=5.8, comprising or supplemented with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 15g/L sucrose, 15g/L glucose, 0.2 mg/L2,4-D, 3 mg/L6-BA and 3g/LPhytagel from MS minimal medium TM Composition; and 150mg/L Tintin was added after sterilization.
In certain embodiments, in step (7), the differentiation medium has a ph=5.8, which comprises or is supplemented with 1mg/L d-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 15g/L sucrose, 15g/L glucose and 3g/L Phytagel from MS minimal medium TM Composition; and 150mg/L Tintin was added after sterilization.
In certain embodiments, in step (8), the pH of the seedling medium = 5.8, which comprises or consists of 1/2MS minimal medium supplemented with 0.25mg/L pyridoxine hydrochloride, 0.25mg/L niacin, 100mg/L inositol, 0.05mg/L thiamine hydrochloride, 15g/L sucrose, 1mM isoleucine and 8g/L agar; and 100mg/L Tintin is added after sterilization; in certain embodiments, the methods described above use one or more of the media described above. In certain preferred embodiments, the methods described above use a combination of 6 media as described above.
In certain embodiments, the 1/2MS minimal medium comprises 2.165g/L MS salts.
In certain embodiments, the MS minimal medium comprises 4.33g/L MS salts.
In certain embodiments, the methods described above use one or more of the media described above. In certain preferred embodiments, the methods described above use a combination of all media described above.
In certain embodiments, the method as described above, wherein, in step (1), the seeds of broom corn millet are used as explants and inoculated on induction medium to obtain primary calli.
In certain embodiments, as described above, in step (1), mature seeds of broom corn millet are sterilized, palea and lemma are removed, sterilized with 75% alcohol for two minutes, and rinsed three to four times with sterilized deionized water for 2 minutes each; the sterilized and washed seeds were placed on sterile filter paper until they were thoroughly dried, then the seeds were inoculated on an induction medium, and after culturing for 20 days at 28℃in the dark, they were transferred to a fresh induction medium until white yellowish primary calli were isolated.
In certain embodiments, a method as described above, wherein, in step (2), the expression vector containing the gene of interest and the hygromycin resistance gene is infected with primary callus by agrobacterium tumefaciens, such that the gene of interest and the hygromycin resistance gene are integrated into the genome of the primary callus.
In certain embodiments, the strain of agrobacterium tumefaciens is EHA105.
In certain embodiments, 300 μl of agrobacterium tumefaciens EHA105 bacterial fluid containing the vector is pipetted into 25ml LB and 50mg/L rifampicin and 100mg/L kanamycin are added and cultured overnight at 28 ℃; then centrifuged for 22min, the supernatant discarded and resuspended in liquid co-culture medium to od600=1.8; incubating at 28 ℃ until the OD600 = 2.0-3.0, and placing on ice for standby to obtain agrobacterium tumefaciens bacteria liquid; wherein the vector contains a gene of interest and a hygromycin resistance gene.
In certain embodiments, a method as described above, wherein, in step (3), the embryogenic callus obtained in step (2) is divided into small pieces of 2mm-3mm, picked up and placed in a co-culture medium containing a liquid, placed on ice for pre-cooling for 20min, then placed in the agrobacterium tumefaciens bacterial solution, and incubated for half an hour at 26 ℃; the calli were then transferred to solid co-culture medium at 22℃for 3 days in the dark.
In certain embodiments, the method as described above, wherein, in step (4), the induction medium further comprises 150mg/L Timentin.
In certain embodiments, in step (4), the co-cultured calli are transferred to induction medium containing 150mg/L Timentin and dark cultured at 28℃for 15 days.
In certain embodiments, the method as described above, wherein, in step (5), the product obtained in step (4) is placed in a screening medium containing 50mg/L hygromycin, and dark-cultured at 28℃for 7-10 days to screen calli containing hygromycin resistance gene.
In certain embodiments, the method as described above, wherein, in step (6), the well-grown callus obtained after the screening of step (5) is inoculated into a pre-differentiation medium, and the pre-differentiation medium is transferred to an illumination culture room for culturing for 14 days, and a layer of gauze is covered thereon to prevent the illumination from being too strong.
In certain embodiments, the method as described above, wherein, in step (7), the differentiated, greenish callus obtained in step (6) is transferred to a differentiation medium to allow the callus to root.
In certain embodiments, a method as described above, wherein, in step (8), seedlings with leaf lengths exceeding 3cm are transferred into a seedling medium to allow the seedlings of the callus to grow.
Definition of terms
In the present application, unless otherwise indicated, scientific and technical terms used herein have the meanings commonly understood by one of ordinary skill in the art. Further, the procedures of molecular genetics, nucleic acid chemistry, molecular biology, biochemistry, cell culture, microbiology, cell biology, genomics and recombinant DNA, etc., as used herein, are all conventional procedures widely used in the corresponding field. Meanwhile, in order to better understand the present application, definitions and explanations of related terms are provided below.
As used herein, the term "callus" refers to new tissue formed by cutting out a portion of an organ, tissue or seed of a plant, and properly culturing the tissue. Callus did not differentiate, but only a mass of parenchyma cells. Generally, under the conditions of proper illumination, temperature, certain nutrients, hormones and the like, the callus can differentiate and produce various organs and tissues of the plant, so that a complete plant can be developed.
As used herein, the term "primary callus" refers to tissue that is first formed after a portion of a plant's organ, tissue or seed has been excised, suitably cultured.
As used herein, the term "secondary calli" refers to tissues that have been formed by the first callus, then excised again to form a portion, and then cultured as appropriate to form the second callus.
As used herein, the term "tertiary secondary callus" refers to a tissue formed by the secondary callus, after which a portion is excised again, cultured appropriately, and formed the third time.
As used herein, the term "MS medium" refers to a medium designed by Murashige and Skoog in 1962 for tobacco cell culture, which is characterized by higher concentration of inorganic salts and ions, can meet the nutritional and physiological needs of plant cells, and is a relatively common medium in plant callus culture.
In certain embodiments, the MS medium comprises the basic components that make up the medium, e.g., sucrose, agar.
In certain embodiments, the MS medium further comprises inorganic salts and ions required for plant growth, for example, ammonium nitrate, potassium nitrate, calcium chloride, magnesium sulfate, potassium dihydrogen phosphate, potassium iodide, boric acid, zinc sulfate, copper sulfate, or iron sulfate.
In certain embodiments, the MS medium further comprises an MS salt.
Advantageous effects of the application
Compared with the prior art, the application establishes the genetic transformation method of millet for the first time. Further, the applicant has repeatedly searched for optimizing a plurality of steps of the established broom corn millet genetic transformation method. Firstly, selecting mature seeds of plants as explants, wherein the sources are rich, and the acquisition period is short; secondly, on the basis of selecting seeds as explants, primary callus is selected for infection of agrobacterium, so that the transformation efficiency is further improved, and the transformation method is optimized; finally, by adjusting the culture medium used in the callus culture process, the optimal culture medium combination is obtained, the transformation efficiency is further improved, and the transformation method is optimized. Thus, the efficient broom corn millet genetic transformation method is obtained.
Embodiments of the present application will be described in detail below with reference to the accompanying drawings and examples, but it will be understood by those skilled in the art that the following drawings and examples are only for illustrating the present application and are not to be construed as limiting the scope of the present application. Various objects and advantageous aspects of the present application will become apparent to those skilled in the art from the following detailed description of the preferred embodiments and the accompanying drawings.
Drawings
FIG. 1 is a schematic representation of a binary vector T-DNA for genetic transformation of broom corn millet in example 2, which contains hygromycin resistance gene (hyg R) and green fluorescent protein Gene (GFP).
FIG. 2 is a flow chart of Agrobacterium-mediated genetic transformation of millet in example 2, wherein FIG. 2a is calli after three days of co-culture (open field on the left, fluorescent field on the right); FIG. 2b shows calli after hygromycin screening (bright field on the left, fluorescent field on the right); FIG. 2c is calli starting pre-differentiation (bright field on the left, fluorescent field on the right); FIG. 2d shows calli that begin to differentiate (bright field on the left, fluorescent field on the right); FIG. 2e shows positive seedlings to be transplanted to soil (bright field on the left, fluorescent field on the right); FIG. 2f shows harvested T1 generation seeds (bright field left and fluorescent field right).
FIG. 3 is a graph showing the results of PCR identification of transgenic broom corn millet plants in example 3, wherein M represents a DNA marker; w represents a non-transgenic wild type WT broom corn millet plant; CK-represents the negative control (no DNA template) of the PCR system; 1-9 respectively represent different converted broom corn millet plants; ck+ represents a transformation vector plasmid.
FIG. 4 shows the results of a concentration gradient experiment for hygromycin selection as used in example 3, wherein FIG. 4a (bright field), 4b (fluorescent field) is hygromycin-free treatment medium (normal callus left, positive transformed callus right); FIG. 4c (open field), 4d (fluorescent field) 30mg/L hygromycin treatment medium (left normal callus, right positive transformed callus); FIG. 4e (open field), 4f (fluorescent field) 50mg/L hygromycin treatment medium (left normal callus, right positive transformed callus).
Sequence information
The information of the partial sequences to which the present application relates is provided in table 1 below.
Table 1: description of the sequence
Detailed Description
The application will now be described with reference to the following examples, which are intended to illustrate the application, but not to limit it.
The experiments and methods described in the examples were performed substantially in accordance with conventional methods well known in the art and described in various references unless specifically indicated. For example, for the conventional techniques of immunology, biochemistry, chemistry, molecular biology, microbiology, cell biology, genomics and recombinant DNA used in the present application, reference may be made to Sambrook (Sambrook), friech (Fritsch) and manitis (Maniatis), molecular cloning: laboratory Manual (MOLECULAR CLONING: A LABORATORY MANUAL), edit 2 (1989); the handbook of contemporary molecular biology (CURRENT PROTOCOLS IN MOLECULAR BIOLOGY) (edited by f.m. ausubel (f.m. ausubel) et al, (1987)); series (academic publishing company) of methods in enzymology (METHODS IN ENZYMOLOGY): PCR2: practical methods (PCR 2: A PRACTICAL APPROACH) (M.J. MaxPherson (M.J. MacPherson), B.D. Thoms (B.D. Hames) and G.R. Taylor (G.R. Taylor) editions (1995)), and animal cell CULTURE (ANIMAL CELL CULTURE) (R.I. French Lei Xieni (R.I. Freshney) editions (1987)).
In addition, the specific conditions are not specified in the examples, and the process is carried out according to conventional conditions or conditions recommended by the manufacturer. The reagents or apparatus used were conventional products commercially available without the manufacturer's attention. Those skilled in the art will appreciate that the examples describe the application by way of example and are not intended to limit the scope of the application as claimed. All publications and other references mentioned herein are incorporated by reference in their entirety.
Example 1 obtaining broom corn millet callus
To establish an efficient broom corn millet conversion system, the inventor of the application usesBroom corn milletExplants used for establishing a transformation system are selected from immature embryos, seeds, stem node meristems, young spikes, stem tips and root tips. Among them, there are many restrictions on the acquisition of part of the explants, so that the applicant selects mature seeds of broom corn millet as the explants, and this method can obtain a large amount of explants at any time in the year and be used for preparing callus for transformation.
On the basis of selecting seeds as explants, the applicant found that different generations of calli of the seeds have a large transformation rate difference. Thus, primary, secondary and tertiary calli were prepared for comparison of the subsequent transformation efficiencies in this example.
Preparation of primary callus: sterilizing mature broom corn millet seeds, sterilizing the mature broom corn millet seeds without the lemma and the No. four seed of the Longqiu of the palea with 75% alcohol for two minutes and flushing three to four times (2 minutes each) with sterilized deionized water. Placing sterilized and cleaned broom corn millet mature seeds on sterile filter paper for 15min until the broom corn millet mature seeds are thoroughly dried, inoculating the seeds on a Callus Induction Medium (CIM), culturing for 20 days under a dark condition (28 ℃) and transferring the seeds on a fresh CIM, and separating white yellowish callus after 10-15 days.
Preparation of secondary subculture callus: and transferring a better part of the primary callus which is successfully induced to a new CIM culture medium, and culturing for 14 days to separate secondary callus.
Preparation of three times of subculture calli: and selecting a better part of the secondary subculture callus after 14 days to transfer to a new CIM culture medium, and sorting out the tertiary subculture callus after 14 days of culture.
Wherein, CIM (pH=5.8) of the seed callus induction culture medium is MS basic culture medium added with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L nicotinic acid, 50mg/L inositol, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin and 3g/L Phytagel TM (purchased from Sigma Co., ltd., product number P8169-1 KG); after sterilization, 2mg/L AgNO is added 3 . Wherein the MS minimal medium contains 4.33g/L MS salt (Murashige&Skoog Basal Salt Mixture from the company PHYTOTECH LABS under the accession number M524).
Example 2 obtaining transgenic broom corn millet callus and plants
FIG. 2 is a flowchart of Agrobacterium-mediated genetic transformation of millet in this example, wherein FIG. 2a is calli after three days of co-cultivation (open field on the left, fluorescent field on the right); FIG. 2b shows calli after hygromycin screening (bright field on the left, fluorescent field on the right); FIG. 2c is calli starting pre-differentiation (bright field on the left, fluorescent field on the right); FIG. 2d shows calli that begin to differentiate (bright field on the left, fluorescent field on the right); FIG. 2e shows positive seedlings to be transplanted to soil (bright field on the left, fluorescent field on the right); FIG. 2f shows harvested T1 generation seeds (bright field left and fluorescent field right). The specific experimental steps are as follows:
1) Agrobacterium tumefaciens EHA105 bacterial liquid containing a 35s-GFP gene and hygromycin resistance gene (hyg R) binary vector (figure 1) stored at-80 ℃ is sucked up to 300 mu L and added into 25ml of LB liquid medium added with 50mg/L rifampicin and 100mg/L kanamycin, and centrifuged at 3500R for 22min after overnight culture at 28 ℃ by a shaker (200 rpm), the supernatant is discarded, resuspended to OD600 = 1.8 by liquid co-culture medium (CoIM), incubated to OD600 = 2.0-3.0 at 28 ℃ and 180R, and placed on ice for later use.
2) The three embryogenic calli obtained in the example 1 are respectively divided into small pieces (2 mm-3 mm), picked up and put into a 50ml centrifuge tube containing liquid CoIM, placed on ice for precooling for 20min, and then subjected to incubation at 26 ℃ and 100r for half an hour in the invasion solution prepared in the step (1); the calli were then transferred to solid CoIM and incubated for 3 days at 22℃under dark conditions.
3) Transferring the callus after co-cultivation in the step (2) to CIM added with 150mg/L Tintin, and performing dark cultivation at 28 ℃ for 15 days, and then transferring the callus to SM, performing dark cultivation at 28 ℃ for 7-10 days.
4) Inoculating the callus with good growth condition screened in the step (3) to a pre-differentiation culture medium (PRM), and transferring the culture medium to an illumination culture chamber (26+/-2 ℃;16h light/8h dark), a layer of gauze is covered on the culture medium to prevent the illumination from being too strong, the differentiated and greenish callus is transferred to a differentiation medium (RM) after fourteen days, the differentiated callus is induced to root, seedlings with better growth condition (seedlings with the leaf length exceeding 3 cm) in the medium are transferred into PM after every 15-20 days, and the rest tissues are transferred into a new RM medium.
5) Transplanting the seedlings which grow to more than 15cm after being transplanted into the RM culture medium in the step (4) into soil, and harvesting the T1 generation seeds about 4 months.
The agrobacterium tumefaciens EHA105 carries a binary vector containing hygromycin resistance gene (hyg R) and green fluorescent protein Gene (GFP).
The coculture medium CoIM (pH=5.4) was added with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 50mg/L inositol, 0.1mg/L thiamine hydrochloride, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin to MS minimal medium, and 3g/L Phytagel was added to the solid coculture medium TM (200. Mu.M/L acetosyringone after sterilization).
The resistant callus screening culture medium SM (pH=5.8) is prepared by adding 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L nicotinic acid, 50mg/L inositol, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin and 3g/L Phytagel to MS basic culture medium TM (after sterilization +2mg/L AgNO3, +50mg/L hygromycin, +150mg/L Tintin (which is a novel gram-negative antibiotic, acting to inhibit Agrobacterium growth, purchased from Solarbio Co., under the designation T8660)).
The pre-differentiation culture medium PRM (pH=5.8) is prepared by adding 1 mg/Ld-biotin, 0.5mg/L pyridoxine hydrochloride and 0.5mg/L smoke to MS basic culture mediumAcid, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 15g/L sucrose, 15g/L glucose, 0.2 mg/L2,4-D, 3 mg/L6-BA, 3g/L Phytagel TM (after sterilization +150 mg/LTimentin).
The differentiation medium RM (pH=5.8) is prepared by adding 1mg/L d-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L nicotinic acid, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 15g/L sucrose, 15g/L glucose and 3g/L LPhytagel into MS basic culture medium TM (150 mg/L Tintin after sterilization).
The seedling culture medium PM (pH=5.8) is 1/2MS minimal medium added with 0.25mg/L pyridoxine hydrochloride, 0.25mg/L nicotinic acid, 100mg/L inositol, 0.05mg/L thiamine hydrochloride, 15g/L sucrose, 1mM isoleucine, 8g/L agar (after sterilization +100 mg/LTimentin). Wherein the 1/2MS minimal medium contained 2.165g/L MS salt (Murashige & Skoog Basal Salt Mixture, available from PHYTOTECH LABS Co., ltd., cat. M524).
Example 3 molecular characterization of transgenic broom corn millet plants obtained by hygromycin resistance screening
In this example, the transformation efficiencies of the calli and plants obtained in example 2 were respectively examined by PCR amplification methods as follows:
1. transformation efficiency of callus
DNA is extracted from 2-5mm callus after about 10 days of screening culture by a CTAB method, and PCR amplification of exogenous gene (Hyg R) is performed, so that the method can be used for identifying positive transgenic broom corn millet callus.
The PCR primers for detecting the exogenous gene (Hyg R) are 35s-Hyg-F and 35s-Hyg-R (the nucleotide sequences are shown as SEQ ID NO:3 and SEQ ID NO: 4).
The amplification conditions for PCR were: 95 ℃ for 5min; then, 33 cycles were performed, each cycle being conditioned. 95 ℃ for 30s;58 ℃ for 30s;72 ℃,1min for 30s; and finally, at 72 ℃ for 10min.
Successful transformation of each callus (hyg R gene identified) and successful expression of GFP gene (visible as distinct fluorescence under a fluorescent field) was considered successful, and each callus was able to successfully transform and differentiate into viable seedlings, considered a successful transformation event.
2. Transformation efficiency of plants
And (3) taking transgenic broom corn millet plants grown in a greenhouse for 1 month, taking leaves with the top of 1cm, extracting DNA by a CTAB method, and carrying out PCR amplification of exogenous genes (Hyg R) to identify positive transgenic broom corn millet plants.
The PCR primers for detecting the exogenous gene (Hyg R) are 35s-Hyg-F and 35s-Hyg-R (the nucleotide sequences are shown as SEQ ID NO:3 and SEQ ID NO: 4).
The amplification conditions for PCR were: 95 ℃ for 5min; then, 33 cycles were performed, each cycle being conditioned. 95 ℃ for 30s;58 ℃ for 30s;72 ℃,1min for 30s; and finally, at 72 ℃ for 10min.
The genetic transformation efficiency of the broom corn millet is achieved through the number of successful transformation events (the number of calli which can be successfully transformed and differentiated to contain exogenous genes): the number of callus blocks before the infection of agrobacterium is calculated.
3. Results
The PCR identification junction of the transgenic broom corn millet plant in the embodiment is shown in fig. 3, wherein M represents a DNA marker; w represents a non-transgenic wild type WT broom corn millet plant; CK-represents the negative control (no DNA template) of the PCR system; 1-9 respectively represent different converted broom corn millet plants; ck+ represents a transformation vector plasmid.
TABLE 1 relationship between callus number of times and transformation rate
Experimental results show that the primary callus is more suitable for the broom corn millet transformation system established by the application, and the transformation efficiency is obviously better than that of the secondary callus and the tertiary callus.
EXAMPLE 4 callus culture
From the results of the above examples (Table 1), the transformation rate was greatly reduced from callus to final emergence. Therefore, the applicant also compares the culture methods of various calli in the process of establishing the broom corn millet conversion system, and obtains an optimized broom corn millet conversion system.
The present application was carried out in a number of parallel experiments according to the method described in examples 1-3, except that in the procedure of example 2, different media were used to treat the calli, as follows:
1. first experiment group
Co-culture Medium CoIM (pH=5.4) 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L nicotinic acid, 50mg/L inositol, 0.1mg/L thiamine hydrochloride, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin were added to MS minimal medium, and 3g/LPhytagel was added to solid co-culture medium TM (200. Mu.M/L acetosyringone after sterilization).
Resistant callus screening Medium SM (pH=5.8) 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L nicotinic acid, 50mg/L inositol, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin, 3g/L Phytagel were added to MS minimal medium TM (after sterilization +2mg/LAgNO3, +50mg/L hygromycin, +150mg/L Tintin).
Pre-fractionation Medium PRM (pH=5.8) 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L nicotinic acid, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 15g/L sucrose, 15g/L glucose, 0.2 mg/L2,4-D, 3 mg/L6-BA, 3g/L Phytagel were added to MS minimal medium TM (after sterilization +150 mg/LTimentin).
Differentiation Medium RM (pH=5.8) 1mg/L d-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L nicotinic acid, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 15g/L sucrose, 15g/L glucose, 3g/LPhytagel were added to MS minimal medium TM (150 mg/L Tintin after sterilization).
Seedling medium PM (ph=5.8) was 1/2MS minimal medium supplemented with 0.25mg/L pyridoxine hydrochloride, 0.25mg/L niacin, 100mg/L inositol, 0.05mg/L thiamine hydrochloride, 15g/L sucrose, 1mM isoleucine, 8g/L agar (after sterilization +100mg/L Timentin).
2. Second experiment group
The experimental group was intended to investigate the effect of hygromycin content in the SM medium on callus, and therefore the method of the experimental group was identical to the previous experimental group, except that three different SM media were used, the specific formulation was as follows:
(1) Formula I: SM (pH=5.8) 1mg/L D-Biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L nicotinic acid, 50mg/L inositol, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin, 3g/L Phytagel were added to MS minimal medium TM (after sterilization +2mg/L AgNO3, +150mg/L Tintin).
(2) And the formula II: SM (pH=5.8) 1mg/L D-Biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L nicotinic acid, 50mg/L inositol, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin, 3g/L Phytagel were added to MS minimal medium TM (after sterilization +2mg/L AgNO3, +30mg/L hygromycin, +150mg/L Tintin).
(3) And the formula III: SM (pH=5.8) 1mg/L D-Biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L nicotinic acid, 50mg/L inositol, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin, 3g/L Phytagel were added to MS minimal medium TM (after sterilization +2mg/L AgNO3, +50mg/L hygromycin, +150mg/L Tintin).
The results of the second experimental group are shown in fig. 4, fig. 4a (bright field), 4b (fluorescent field) for hygromycin-free SM medium (normal callus on the left and positive transformed callus on the right); FIG. 4c (open field), results for SM medium (left plain callus, right positive transformed callus) at 30mg/L hygromycin for 4d (fluorescent field); FIG. 4e (open field), results for SM medium (left plain callus, right positive transformed callus) at 50mg/L hygromycin for 4f (fluorescent field).
As can be seen from FIG. 4, when 50mg/L hygromycin was contained in the SM medium, the growth of the calli was optimal, and at this concentration, positive calli were seen to grow well, and negative calli were essentially brown and dead.
3. Third experimental group
The experimental group was intended to investigate the effect of RM medium on calli, and therefore the method of the experimental group was identical to the previous experimental group, the only difference being that different RM media were used, the specific formulation being: MS minimal medium added 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 15g/L sucrose, 15g/L glucose, 0.2 mg/L2,4-D, 3 mg/L6-BA, 3g/L Phytagel TM (150 mg/L Tintin after sterilization).
Results: compared with the first experimental group, the callus of the third experimental group using different RM culture medium can not root about 80% of the callus after differentiation and budding, and finally whiten and die, so that the conversion rate is greatly reduced.
4. Fourth experiment group
The experimental group was intended to investigate the effect of the CoIM medium on callus, and therefore the method of the experimental group was identical to the previous experimental group, except that different CoIM media were used, and the specific formulation was as follows: 0.44g/LMS salt, 1 XB 5 vitamin, 68g/L sucrose, 36g/L glucose, 1g/L asparagine, 1g/L casein hydrolysate, 0.2g/L cysteine, 2mg/L2,4-D, (200. Mu.M acetosyringone added after sterilization) (pH=5.2).
Results: callus of the fourth experimental group using a different CoIM medium failed to be transformed successfully, as compared to the first experimental group.
In summary, from the experimental results of this example, it can be seen that the combination of media used in the method of the present application can achieve higher transformation efficiency and better transformation effect than other combinations of media.
Although specific embodiments of the application have been described in detail, those skilled in the art will appreciate that: many modifications and variations of details may be made to adapt to a particular situation and the application is intended to be within the scope of the application. The full scope of the application is given by the appended claims together with any equivalents thereof.
SEQUENCE LISTING
<110> Chinese university of agriculture
<120> broom corn millet genetic transformation method
<130> IDC220146
<160> 4
<170> PatentIn version 3.5
<210> 1
<211> 341
<212> PRT
<213> artificial
<220>
<223> hygromycin resistance Gene (hyg R)
<400> 1
Met Lys Lys Pro Glu Leu Thr Ala Thr Ser Val Glu Lys Phe Leu Ile
1 5 10 15
Glu Lys Phe Asp Ser Val Ser Asp Leu Met Gln Leu Ser Glu Gly Glu
20 25 30
Glu Ser Arg Ala Phe Ser Phe Asp Val Gly Gly Arg Gly Tyr Val Leu
35 40 45
Arg Val Asn Ser Cys Ala Asp Gly Phe Tyr Lys Asp Arg Tyr Val Tyr
50 55 60
Arg His Phe Ala Ser Ala Ala Leu Pro Ile Pro Glu Val Leu Asp Ile
65 70 75 80
Gly Glu Phe Ser Glu Ser Leu Thr Tyr Cys Ile Ser Arg Arg Ala Gln
85 90 95
Gly Val Thr Leu Gln Asp Leu Pro Glu Thr Glu Leu Pro Ala Val Leu
100 105 110
Gln Pro Val Ala Glu Ala Met Asp Ala Ile Ala Ala Ala Asp Leu Ser
115 120 125
Gln Thr Ser Gly Phe Gly Pro Phe Gly Pro Gln Gly Ile Gly Gln Tyr
130 135 140
Thr Thr Trp Arg Asp Phe Ile Cys Ala Ile Ala Asp Pro His Val Tyr
145 150 155 160
His Trp Gln Thr Val Met Asp Asp Thr Val Ser Ala Ser Val Ala Gln
165 170 175
Ala Leu Asp Glu Leu Met Leu Trp Ala Glu Asp Cys Pro Glu Val Arg
180 185 190
His Leu Val His Ala Asp Phe Gly Ser Asn Asn Val Leu Thr Asp Asn
195 200 205
Gly Arg Ile Thr Ala Val Ile Asp Trp Ser Glu Ala Met Phe Gly Asp
210 215 220
Ser Gln Tyr Glu Val Ala Asn Ile Phe Phe Trp Arg Pro Trp Leu Ala
225 230 235 240
Cys Met Glu Gln Gln Thr Arg Tyr Phe Glu Arg Arg His Pro Glu Leu
245 250 255
Ala Gly Ser Pro Arg Leu Arg Ala Tyr Met Leu Arg Ile Gly Leu Asp
260 265 270
Gln Leu Tyr Gln Ser Leu Val Asp Gly Asn Phe Asp Asp Ala Ala Trp
275 280 285
Ala Gln Gly Arg Cys Asp Ala Ile Val Arg Ser Gly Ala Gly Thr Val
290 295 300
Gly Arg Thr Gln Ile Ala Arg Arg Ser Ala Ala Val Trp Thr Asp Gly
305 310 315 320
Cys Val Glu Val Leu Ala Asp Ser Gly Asn Arg Arg Pro Ser Thr Arg
325 330 335
Pro Arg Ala Lys Lys
340
<210> 2
<211> 245
<212> PRT
<213> artificial
<220>
<223> Green fluorescent protein Gene (GFP)
<400> 2
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Ser Ala Trp
225 230 235 240
Thr Ser Cys Thr Trp
245
<210> 3
<211> 20
<212> DNA
<213> artificial
<220>
<223> 35s-Hyg-F
<400> 3
cggtcggcat ctactctatt 20
<210> 4
<211> 20
<212> DNA
<213> artificial
<220>
<223> 35s-Hyg-R
<400> 4
aaacctcctc ggattccatt 20
Claims (10)
1. A method for genetic transformation of broom corn millet, the method comprising:
step (1): taking broom corn millet seeds as explants to obtain primary callus;
step (2): transforming target genes and hygromycin resistance genes into the primary callus obtained in the step (1) through agrobacterium;
step (3): putting the product obtained in the step (2) into a co-culture medium for co-culture;
step (4): placing the product obtained in the step (3) into an induction culture medium for culture;
step (5): placing the product obtained in the step (4) into a screening culture medium containing 50mg/L hygromycin to screen callus containing hygromycin resistance genes;
step (6): placing the product obtained in the step (5) into a pre-differentiation culture medium to enable the callus to bud;
step (7): placing the product obtained in the step (6) into a differentiation medium to root the callus;
step (8): placing the product obtained in the step (7) into a seedling culture medium so as to enable seedlings of the callus to grow;
preferably, the amino acid sequence of the target gene is shown as SEQ ID NO. 2;
preferably, the amino acid sequence of the hygromycin resistance gene is shown as SEQ ID NO. 1.
2. The method of claim 1, having one or more features selected from the group consisting of:
(1) In step (3), the co-culture medium has a ph=5.4, which comprises or consists of MS minimal medium supplemented with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 50mg/L inositol, 0.1mg/L thiamine hydrochloride, 30g/L sucrose and 2mg/L2,4-D and 0.5mg/L kinetin; and 200 mu M/L acetosyringone is added after sterilization;
preferably, the co-culture medium is a solid co-culture medium; preferably, the solid co-culture medium further comprises 3g/L Phytagel TM ;
(2) In step (4), the induction medium has a ph=5.8, which comprises or is supplemented with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 50mg/L inositol, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin and 3g/L Phytagel from MS minimal medium TM Composition; and, after sterilization, 2mg/L AgNO is added 3 ;
(3) In step (5), the screening medium has a ph=5.8, which comprises or is supplemented with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 50mg/L inositol, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 30g/L sucrose, 2mg/L2,4-D,0.5mg/L kinetin and 3g/L Phytagel from MS minimal medium TM Composition; and, after sterilization, 2mg/L AgNO is added 3 50mg/L hygromycin, and 150mg/L Timentin;
(4) In step (6), the pre-fractionation medium has a ph=5.8, which comprises or is supplemented with 1mg/L D-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 15g/L sucrose, 15g/L glucose, 0.2 mg/L2,4-D, 3 mg/L6-BA and 3g/L Phytagel from MS minimal medium TM Composition; and 150mg/L Tintin is added after sterilization;
(5) In step (7), the differentiation medium has a ph=5.8, which comprises or is supplemented with 1mg/L d-biotin, 0.5mg/L pyridoxine hydrochloride, 0.5mg/L niacin, 300mg/L casein hydrolysate, 0.1mg/L thiamine hydrochloride, 0.6mg/L copper sulfate, 15g/L sucrose, 15g/L glucose and 3g/L Phytagel TM Composition; and 150mg/L Tintin is added after sterilization;
(6) In step (8), the ph=5.8 of the seedling medium comprising or consisting of 1/2MS minimal medium supplemented with 0.25mg/L pyridoxine hydrochloride, 0.25mg/L niacin, 100mg/L inositol, 0.05mg/L thiamine hydrochloride, 15g/L sucrose, 1mM isoleucine and 8g/L agar; and 100mg/L Tintin is added after sterilization;
preferably, the 1/2MS minimal medium comprises or consists of 4.33g/L MS salts;
preferably, the MS minimal medium comprises or consists of 2.165g/L MS salts.
3. The method of claim 1 or 2, wherein, in step (1), seeds of broom corn millet are used as explants and inoculated on induction medium to obtain primary calli;
preferably, in the step (1), mature seeds of broom corn millet are sterilized, lemma and palea are removed, sterilized with 75% alcohol for two minutes, and rinsed three to four times with sterilized deionized water for 2 minutes each; the sterilized and washed seeds were placed on sterile filter paper until they were thoroughly dried, then the seeds were inoculated on an induction medium, and after culturing for 20 days at 28℃in the dark, they were transferred to a fresh induction medium until white yellowish primary calli were isolated.
4. A method according to any one of claims 1 to 3, wherein in step (2) an expression vector containing a gene of interest and a hygromycin resistance gene is infected with primary callus by agrobacterium tumefaciens such that the gene of interest and hygromycin resistance gene are integrated into the genome of the primary callus;
preferably, the strain of agrobacterium tumefaciens is EHA105;
preferably, 300. Mu.L of Agrobacterium tumefaciens EHA105 bacterial liquid containing the vector is pipetted into 25ml LB and 50mg/L rifampicin and 100mg/L kanamycin are added and cultured overnight at 28℃before step (2); then centrifuged for 22min, the supernatant discarded and resuspended in liquid co-culture medium to od600=1.8; incubating at 28 ℃ until the OD600 = 2.0-3.0, and placing on ice for standby to obtain agrobacterium tumefaciens bacteria liquid; wherein the vector contains a gene of interest and a hygromycin resistance gene.
5. The method according to any one of claims 1 to 4, wherein, in step (3), the embryogenic callus obtained in step (2) is divided into small pieces of 2mm to 3mm, picked up and placed in a co-culture medium containing a liquid, placed on ice for pre-cooling for 20min, then placed in the agrobacterium tumefaciens bacteria solution, and incubated for half an hour at 26 ℃; the calli were then transferred to solid co-culture medium at 22℃for 3 days in the dark.
6. The method of any one of claims 1-5, wherein in step (4), the induction medium further comprises 150mg/L Timentin;
preferably, in step (4), the co-cultured calli are transferred to induction medium containing 150mg/L Timentin and dark cultured at 28℃for 15 days.
7. The method according to any one of claims 1 to 6, wherein, in step (5), the product obtained in step (4) is placed in a screening medium containing 50mg/L hygromycin and is dark-cultured at 28℃for 7 to 10 days to screen calli containing a hygromycin resistance gene.
8. The method according to any one of claims 1 to 7, wherein, in step (6), the selected well-grown callus obtained in step (5) is inoculated into a pre-differentiation medium, and the pre-differentiation medium is transferred to an illumination culture room for culturing for 14 days, and a gauze layer is covered on the pre-differentiation medium to prevent the illumination from being too strong.
9. The method according to any one of claims 1 to 8, wherein, in step (7), the differentiated green-turning callus obtained in step (6) is transferred to a differentiation medium to root the callus.
10. The method according to any one of claims 1 to 9, wherein in step (8) seedlings with leaf lengths exceeding 3cm are transferred into a seedling medium to allow the seedlings of the calli to grow.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210565362.XA CN117143907A (en) | 2022-05-23 | 2022-05-23 | Broom corn millet genetic transformation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210565362.XA CN117143907A (en) | 2022-05-23 | 2022-05-23 | Broom corn millet genetic transformation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117143907A true CN117143907A (en) | 2023-12-01 |
Family
ID=88885453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210565362.XA Pending CN117143907A (en) | 2022-05-23 | 2022-05-23 | Broom corn millet genetic transformation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117143907A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118703692A (en) * | 2024-08-27 | 2024-09-27 | 中国热带农业科学院三亚研究院 | Single-copy broom corn millet gene and method for detecting insertion copy number of exogenous gene in broom corn millet by using same |
-
2022
- 2022-05-23 CN CN202210565362.XA patent/CN117143907A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118703692A (en) * | 2024-08-27 | 2024-09-27 | 中国热带农业科学院三亚研究院 | Single-copy broom corn millet gene and method for detecting insertion copy number of exogenous gene in broom corn millet by using same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080229447A1 (en) | Transformation of immature soybean seeds through organogenesis | |
CA2570626C (en) | Method for agrobacterium transformation for dihaploid corn plants | |
JP2005535312A (en) | Method for transforming soybean | |
JP2000510325A (en) | Method for propagation and / or selection of plant material | |
MX2007002083A (en) | Methods for plant regeneration, transformation and production of insect resistant transgenic okra. | |
CN116042698A (en) | Method for establishing rapid and efficient alfalfa hairy root transformation system | |
WO1992000371A1 (en) | Rose plants and methods for their production and genetic transformation | |
CN117143907A (en) | Broom corn millet genetic transformation method | |
AU744496B2 (en) | Method of genetically transforming banana plants | |
EP0808372A1 (en) | Agrobacterium mediated transformation of eucalyptus | |
CN108588002B (en) | Method for obtaining embryogenic callus of millet for genetic transformation and genetic transformation | |
CN113755521B (en) | Construction method of agrobacterium-mediated strawberry 'sweet Charles' genetic transformation system | |
CN114164229B (en) | Method for obtaining novel strawberry germplasm with high regeneration efficiency by using CRISPR/Cas9 gene knockout vector of FvePILS5 gene and application | |
CN112063597B (en) | Maize multi-copper oxidase coding gene ZmDEK559-2 and application thereof | |
CN104673803B (en) | Application of gene methylation in regulation of gene expression | |
KR101677483B1 (en) | Antibiotic marker-free transgenic rice with over-expressed of OsNAS3 gene from Oryza sativa enhancing content of seed inorganic compounds | |
CN116814651B (en) | Application of oat flower MYB4a transcription factor in regulating and controlling plant flower column elongation | |
WO2024183168A1 (en) | Use of soybean gmsammt gene in regulation of vegetable protein content and/or yield | |
CN118620927A (en) | Eggplant SmNPC gene and application thereof | |
CN118703564A (en) | Carrier and application thereof in improving production efficiency of momordica grosvenori fruits | |
CN118086370A (en) | Application of transcription factor OsbZIP62 in negative regulation of rice seed vigor | |
CN115991756A (en) | Method for improving tomato fruit yield and tomato fruit lycopene content under dim light condition | |
CN118222585A (en) | Drought-resistant gene of alfalfa MfWRKY and application thereof | |
CN118272423A (en) | Application of transcription factor OsbZIP05 in negative regulation of rice seed vigor | |
CN117625683A (en) | Application of FvJAZ8 gene in regulation and control of strawberry stolons |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |